MedPath

study of hyperbaric Ropivacaine and hyperbaric levo Bupivacaine for subarachnoid block in lower limb orthopaedic surgery

Phase 4
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2024/01/061853
Lead Sponsor
RIMS, RANCHI
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1) 18 to 65 years of either sex

2) Weight of 45 to 75 kgs

3)Height of 150 to 180cms

4) Patients undergoing lower limb orthopaedic surgery

5) ASA grade I & II

Exclusion Criteria

1)Patient unwilling

2)Any bleeding disorder and patient on anticoagulants.

3) Neurological and musculoskeletal disease.

4) History of any allergy to local anaesthetic agents and signs of allergy to lidocaine test dose.

5)Significant history of drug/alcohol abuse

6) Patients with contradindication for regional anaesthesia

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
to determine the time of onset, time to attainment of maximum level, maximum level attained & duration of sensory blockade. <br/ ><br>Timepoint: From the time of giving subarachnoid block till the end of surgery and postoperative period (6hrs) <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
1)To determine the time of onset, time to attainment of maximum bromage score, maximum bromage score reached and duration of motor blockade. <br/ ><br>2)To assess the hemodynamic changes like- blood pressure, heart rate, urine output during the period of spinal anesthesia. <br/ ><br>3)To enhance patients safety and faster recoveryTimepoint: From the time of giving subarachnoid block till the end of surgery and postoperative period (12hrs) <br/ ><br>
© Copyright 2025. All Rights Reserved by MedPath